Inhibikase Therapeutics, Inc. (IKT)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
Feb 23, 16:00
1.82
+0.02
(+1.11%)
After-Hours: 17:23
Inhibikase Therapeutics Market Cap : 218.28M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Beta Bionics, Inc. | 606.66M |
| ACADIA Pharmaceuticals, Inc. | 4.187B |
| Agenus, Inc. | 110.59M |
| Alnylam Pharmaceuticals, Inc. | 43.71B |
| Savara, Inc. | 1.164B |
Market Cap Related Metrics
| Price to Book Value | 2.994 |
| Price | 1.80 |
| Earnings Yield | -31.69% |